Global 2017 Bioprinting Markets Materials, Equipment and Applications Report - Projections to 2027 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Bioprinting Markets: Materials, Equipment and Applications - 2017 to 2027" report to their offering.

The report identifies the most commercially important technologies, materials and applications for bioprinting. It includes ten-year forecasts of bioprinting materials, hardware and applications, along with granular information on current pricing for both bioprinters and printing materials. The report also provides information on which companies and institutions are using bioprinters today and which printers they are using. The report was compiled after extensive interviewing of key executives in the industry.

There is also an analysis of the diverse market for bioinks. materials, which include polymers, ceramics, cells, cell aggregates, peptides, growth factors, hydrogels, scaffold components, and others.

Findings From the Report:

  • Although, the leading professional bioprinter firms themselves are today often small. (See attached chart), major multinationals now have bioprinting programs. Such firms include Astellas Pharma, Bristol-Meyers Squibb, Merck, Novartis, Procter and Gamble and Roche. By 2027, SmarTech believes there will be over 5,000 bioprinting systems installed worldwide.
  • Another driver for bioprinting going forward will be the growing availability of low-cost bioprinters systems. Systems under $20,000 will enable bioprinting to be much more widely used both in industry and in smaller academic institutions. These will enable the creation of entirely new services in much the same way that low-cost gene splicing machines have done.
  • Although currently a niche sector, bioprinting will take off rapidly in the next few years as today's trials turn into commercial applications. SmarTech anticipates a rush to fund bioprinting startups as sales of bioprinters will double between 2016 and 2021. Firms seeking to establish a foothold in this emerging market are turning up both R&D and market development activity.

Key Topics Covered:

Chapter One: The 3D Bioprinting Market in 2016

1.1 Key Trends in 3D Bioprinting Driving Hardware Demand

  • Analysis of Commercially Viable 3D Bioprinting Applications
  • The Promise of 3D-Printed Organs
  • How 3D Cell Culture is Affecting Medical Research

1.2 The 3D Bioprinting Industry

  • The Market for Bioprinting Materials
  • How Low Cost and Open Source Bioprinting is Affecting the Competitive Landscape

Chapter Two: 3D Bioprinting Processes, Hardware and Materials

2.1 Origins of Bioprinting

  • Scaffold Based (Indirect) Bioprinting
  • Scaffold-free Bioprinting

2.2 Laser-Assisted Bioprinting (LaBP) Methods

  • LIFT (Laser-Induced Forward Transfer)
  • LGDW (Laser Guided Direct Writing)

2.3 Stereolithography

  • Microstereolithography (MSTL)
  • Projection-based Microstereolithography (pMSTL)
  • Nanostereolithography (NSTL)
  • Two-Photon Polymerization (2PP)

2.4 Laser Free Bioprinting Methods (LfBP)

  • 3D Bioprinting by Material Jetting
  • 3D Bioprinting by Extrusion

2.5 Other Methods

  • Electrospinning
  • Magnetic Levitation (n3D)
  • The Kenzan Method

2.6 Post Processing: The Bioreactor

2.7 Materials for 3D Bioprinting

  • Characteristics of Bioinks and Bio-consumables
  • Scaffolds
  • Hydrogels
  • Stem Cells
  • Spheroids and Organoids
  • Polymers
  • Ceramics

Chapter Three: The Present and Future of 3D Bioprinting Applications

3.1 Tissue Regeneration

  • Cartilage
  • Skin
  • Bones
  • Blood Vessels

3.2 Complex Organs: the Billion Cell Construct

  • Thyroid and Pancreas
  • Kidney
  • Liver
  • Heart and Valves
  • Brain

3.3 Research

  • Drug Toxicity Testing and Screening
  • In-Vitro Organ Models and the Organ-on-a-Chip
  • Cosmetics

3.4 Cellular Agriculture

  • Meat
  • Other Products

Chapter Four: Analysis of the 3D Bioprinting Competitive Landscape

4.1 Leading Hardware Manufacturers

  • EnvisionTEC
  • RegenHU
  • Advanced Solutions (BioAssemblyBot)
  • 3D Bioprinting Solutions
  • Regenovo
  • GeSIM
  • Cyfuse Biomedical

4.2 Low-Cost Hardware and Commercial Bioink Manufacturers

  • Biobots (U.S.)
  • CELLINK (Europe - Sweden)
  • Rokit (Asia - South Korea)
  • Bio3D (Asia - Singapore)
  • Bioink Solutions

4.3 Major Universities and Associations in 3D Bioprinting Research

  • Harvard: Wyss Institute Lewis Lab
  • International Society for BioFabrication
  • Utrecht University Biofabrication Facility
  • IMS Postech South Korea
  • Northwestern University - Shah TEAM Lab
  • Wake Forest Institute for Regenerative Medicine (WFRIM)
  • Herston Biofabrication Institute

4.4 Commercial Bioprinting Research Firms

  • Organovo
  • Tissue Regeneration Systems
  • Poietis
  • Aspect Biosystems
  • Nano3D Biosciences (n3D)

Chapter Five: Ten-Year 3D Bioprinting Market Forecasts - Hardware, Materials and Research

5.1 Limiting Factors

5.2 The 3D Bioprinting Market: Hardware, Materials and Applications: Ten-Year Forecast

  • Ten-Year Forecast of 3D Bioprinting Hardware Market

5.3 Ten-Year Bioink Forecast

  • Hydrogels and Scaffolding Materials Sales and Demand
  • Scaffolding Materials Sales and Demand
  • Matrix Materials Sales and Demand

5.4 Ten-Year Forecast for 3D Bioprinting Research and Tissue Regeneration Applications

For more information about this report visit


Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biomaterials


Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biomaterials